RYBELSUS® is contraindicated in sufferers with a private or household record of MTC and in sufferers with Multiple Endocrine Neoplasia syndrome variety two (Males 2). Counsel sufferers concerning the possible possibility for MTC with the use of RYBELSUS® and inform them of signs or symptoms of thyroid tumors (e. In https://weightlosspharmaceutic.com/product/rybelsus-semaglutide-3mg-tablets/